Skip to main content
SpringerLink
Log in

Regulating AI in medicine in the United States and Europe

  • Comment
  • Published:

From Nature Machine Intelligence

View current issue Submit your manuscript

The regulatory landscape for artificial intelligence (AI) is shaping up on both sides of the Atlantic, urgently awaited by the scientific and industrial community. Commonalities and differences start to crystallize in the approaches to AI in medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan (FDA, 2021).

  2. Executive Office of the President: Guidance for Regulation of Artificial Intelligence Applications (The White House, 2020).

  3. Proposal for a Regulation Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) (European Commission, 2021).

  4. Vokinger, K. N., Feuerriegel, S. & Kesselheim, A. S. Lancet Digit. Health 3, 337–338 (2021).

    Article  Google Scholar 

  5. Oren, O., Gersh, B. J. & Bhatt, D. L. Lancet Digit. Health 2, 486–488 (2020).

    Article  Google Scholar 

  6. Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) (FDA, 2019).

  7. Lavizzo-Mourey, R. J., Besser, R. E. & Williams, D. R. NEJM 18, 1681–1684 (2021).

    Article  Google Scholar 

  8. Canto, J. G., Rogers, W. & Goldberg, R. J. JAMA 8, 813–822 (2012).

    Google Scholar 

  9. Parikh, R. B., Teeple, S. & Navathe, A. S. JAMA 322, 2377 (2019).

    Article  Google Scholar 

  10. Kausha, A., Altman, R. & Langlotz, C. JAMA 324, 1212 (2020).

    Article  Google Scholar 

  11. Muehlematter, U. J., Daniore, P. & Vokinger, K. N. Lancet Digit. Health 3, 195–203 (2021).

    Article  Google Scholar 

  12. Rajkomar, A. et al. NPJ Digital Med. 1, 18 (2018).

    Article  Google Scholar 

  13. Toscano, F., O’Donnell, E. & Unruh, M. et al. Eur. J. Publ. Health 28, cky213.401 (2018).

    Google Scholar 

  14. Die elektronische Patientenakte (Bundesministerium für Gesundheit, accessed 13 June 2021); https://www.bundesgesundheitsministerium.de/elektronische-patientenakte.html

Download references

Acknowledgements

This study was partially funded by the Swiss National Science Foundation (SNSF).

Author information

Authors and Affiliations

  1. Institute of Law, University of Zurich, Zurich, Switzerland

    Kerstin N. Vokinger

  2. Berkman Klein Center for Internet and Society, Harvard University, Cambridge, MA, USA

    Kerstin N. Vokinger & Urs Gasser

  3. TUM School of Social Sciences and Technology, Technical University of Munich, Munich, Germany

    Urs Gasser

Authors
  1. Kerstin N. Vokinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Urs Gasser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Kerstin N. Vokinger or Urs Gasser.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vokinger, K.N., Gasser, U. Regulating AI in medicine in the United States and Europe. Nat Mach Intell 3, 738–739 (2021). https://doi.org/10.1038/s42256-021-00386-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42256-021-00386-z

  • Springer Nature Limited

This article is cited by

Search

Navigation